Pharma industry expresses concerns over MFN status to India
ISLAMABAD: The Pakistan Pharmaceutical Manufacturers Association (PPMA) has expressed serious concern over the government’s intention of granting Most Favoured Nation (MFN) status to India, which will significantly affect the local pharmaceutical industry, possibly forcing it to close down altogether. A letter written by Chairman PPMA, Khawaja Muhammad Asad, against the move to the government and all chambers, says the expansion of bilateral trade with India under MFN will not have positive impact on the domestic pharmaceutical sector.
The MFN status will significantly impact the local pharmaceutical industry and there are fears of closure of the industry resulting in massive job cuts.
PPMA sought support and requested the president and prime minister to take up this matter with concerned ministries to save the local pharma industry, which has shown progressive growth over the years. PPMA strongly feels all medicines should be in the negative list and the local pharma industry should be given full government support as it forms the second line of defence in case of war, natural disasters, or epidemics.